Reference : New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers ...
Scientific journals : Article
Human health sciences : Radiology, nuclear medicine & imaging
http://hdl.handle.net/2268/10437
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents
English
Oltenfreiter, R. [> > > >]
Staelens, L. [> > > >]
Lejeune, Annabelle [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
Dumont, F. [ > > ]
Frankenne, Francis [ > > ]
Foidart, Jean-Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >]
Slegers, G. [> > > >]
May-2004
Nuclear Medicine & Biology
Pergamon Press
31
4
459-468
Yes (verified by ORBi)
0969-8051
Oxford
United Kingdom
[en] radiolabelled MMP inhibitors ; iodine-123 ; in vitro assay ; in vivo biodistribution ; SPECT ; tumor imaging
[en] Several studies have demonstrated a positive correlation between tumor progression and expression of extracellular proteinases such as matrix metalloproteinases (MMPs). MMP-2 and MMP-9 have become attractive targets for cancer research because of their increased expression in human malignant tumor tissues of various organs, providing a target for medical imaging techniques. Radioiodinated carboxylic and hydroxamic MMP inhibitors 2-(4'-[123]iodo-biphenyl-4-sulfonylainino)-3-(1H-indol-3-yl)-propionic acid (9) and 2-(4'-[I-123] iodo-biphenyl-4-sulfonylamino)-3-(1H-indol-3-yl)-propionamide (11) were synthesized by electrophilic aromatic substitution of the tributylstannyl derivatives and resulted in radiochemical yields of 60% +/- 5% (n - 3) and 70% +/- 5% (n = 6), respectively. In vitro zymography and enzyme assays showed high inhibition capacities of the inhibitors on gelatinases. In vivo biodistribution showed no long-terin accumulation in organs and the possibility to accumulate in the tumor. These results warrant further studies of radioiodinated carboxylic and hydroxamic MNIP inhibitor tracers as potential SPECT tumor imaging agents. (C) 2004 Elsevier Inc. All rights reserved.
http://hdl.handle.net/2268/10437
10.1016/j.nucmedbio.2003.10.013

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Oltenfreiter R Nucl Med Biol 2004.pdf.pdfAuthor postprint446.17 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.